Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Psychometric Validation of the Adapted Traditional Chinese (Hong Kong) Version of the Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ)

Psychometric Validation of the Adapted Traditional Chinese (Hong Kong) Version of the Japanese... Supplemental Digital Content is available in the text http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Spine Wolters Kluwer Health

Psychometric Validation of the Adapted Traditional Chinese (Hong Kong) Version of the Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ)

Download PDF
8 pages

Loading next page...
1
 
/lp/wolters_kluwer/psychometric-validation-of-the-adapted-traditional-chinese-hong-kong-07X7Cb20zu

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
0362-2436
eISSN
1528-1159
DOI
10.1097/BRS.0000000000002287
Publisher site
See Article on Publisher Site

Abstract

Supplemental Digital Content is available in the text

Journal

Spine – Wolters Kluwer Health

Published: Feb 15, 2018

References

  • The cervical spine; an anatomico-pathological study of 70 specimens (using a special technique) with particular reference to the problem of cervical spondylosis
  • Cervical spondylotic myelopathy
  • The morbid anatomy of cervical spondylosis and myelopathy
  • Cervical spondylotic myelopathy: pathophysiology, clinical presentation, and treatment
  • The Adult Spine: Principles and Practice
  • Cervical myelopathy: a complication of cervical spondylosis
  • Cervical spondylotic myelopathy. Clinical syndrome and natural history
  • Comparison of the Japanese Orthopaedic Association (JOA) score and modified JOA (mJOA) score for the assessment of cervical myelopathy: a multicenter observational study
  • An outcome measure for patients with cervical myelopathy: Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ): Part 1
  • Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ): part 2. Endorsement of the alternative item
  • Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire: part 3. Determination of reliability
  • Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ): part 4. Establishment of equations for severity scores. Subcommittee on low back pain and cervical myelopathy, evaluation of the clinical outcome committee of the Japanese Orthopaedic Association
  • Translation, cross-cultural adaptation, and validation of a Chinese version of the Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire
  • Unrecognized shoulder disorders in treatment of cervical spondylosis presenting neck and shoulder pain
  • Translation and validation study of Chinese versions of the neck disability index and the neck pain and disability scale
  • EuroQol: a new facility for the measurement of health-related quality of life
  • Is the SF-12 version 2 Health Survey a valid and equivalent substitute for the SF-36 version 2 Health Survey for the Chinese?
  • Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist
  • Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials
  • Validation of the reliability of the Thai version of the Japanese Orthopaedic Association Cervical Myelopathy Evaluation Questionnaire (JOACMEQ)
  • An outcome measure of functionality and quality of life in patients with cervical myelopathy
  • The Neck Disability Index: a study of reliability and validity
  • The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients
  • Valuing health-related quality of life in type 2 diabetes patients in China
  • Psychometric validation of the EuroQoL 5-Dimension 5-Level (EQ-5D-5L) in Chinese patients with adolescent idiopathic scoliosis
  • EQ-5D-5L and SF-6D utility measures in symptomatic benign thyroid nodules: acceptability and psychometric evaluation
  • Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis
  • Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets
  • Chinese time trade-off values for EQ-5D health states
  • Focus on Cervical Myelopathy